國立虎尾科技大學 |

The Nociceptin/Orphanin FQ peptide receptor

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The Nociceptin/Orphanin FQ peptide receptor/ edited by Mei-Chuan Ko, Girolamo Calo.
其他作者:	Ko, Mei-Chuan.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	x, 417 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Neurotransmitter receptors. -
電子資源:	https://doi.org/10.1007/978-3-030-20186-9
ISBN:	9783030201869

The Nociceptin/Orphanin FQ peptide receptor
The Nociceptin/Orphanin FQ peptide receptor[electronic resource] /edited by Mei-Chuan Ko, Girolamo Calo. - Cham :Springer International Publishing :2019. - x, 417 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2540171-2004 ;. - Handbook of experimental pharmacology ;v.212..

PART I. The N/OFQ-NOP Receptor System -- 1. The History of N/OFQ and the NOP Receptor -- 2. NOP-Targeted Peptide Ligands -- 3. NOP-Targeted Nonpeptide Ligands -- 4. Pharmacological Assays for Investigating the NOP Receptor -- 5. Electrophysiological Actions of N/OFQ -- 6. NOP Receptor Signaling Cascades -- 7.Regulation of the Genes Encoding the ppN/OFQ and NOP Receptor -- PART II. Biological Actions of NOP Ligands -- 8.NOP-Related Mechanisms in Pain and Analgesia -- 9. NOP-Related Mechanisms in Substance Use Disorders -- 10. NOP Receptor Ligands and Parkinson's Disease -- 11. NOP Ligands for the Treatment of Anxiety and Mood Disorders -- 12. The Nociceptin/Orphanin FQ System and the Regulation of Memory -- 13. N/OFQ-NOP System in Food Intake -- 14. N/OFQ-NOP System in Peripheral and Central Immunomodulation -- 15. N/OFQ-NOP System and Airways -- 16. Effects of NOP-Related Ligands in Nonhuman Primates -- PART III. First Clinical Studies with NOP Ligands -- 17. Nociceptin/Orphanin FQ and Urinary Bladder -- 18. Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors -- 19. Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094) -- 20. Correction to: Electrophysiological Actions of N/OFQ.

The aim of this book is not only to introduce readers with a broad spectrum of biological actions of the NOP receptor, but also to feature a detailed look at the N/OFQ-NOP receptor system, medicinal chemistry, pharmacology, and clinical data of NOP-targeted ligands. This special volume book - for the first time focusing on the NOP receptor - is designed to serve as a useful reference, stimulate more research on the N/OFQ-NOP receptor system, and lead to more development of NOP-related ligands for several therapeutic applications.

ISBN: 9783030201869

Standard No.: 10.1007/978-3-030-20186-9doiSubjects--Topical Terms:

581762
Neurotransmitter receptors.

LC Class. No.: QP364.7 / .N635 2019

Dewey Class. No.: 599.0188

The Nociceptin/Orphanin FQ peptide receptor
LDR:02956nam a2200337 a 4500 001 941596
003 DE-He213
005 20191126153755.0
006 m d
007 cr nn 008maaau
008 200417s2019 gw s 0 eng d
020 $a 9783030201869 $q (electronic bk.)
020 $a 9783030201852 $q (paper)
024 7 $a 10.1007/978-3-030-20186-9 $2 doi
035 $a 978-3-030-20186-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QP364.7 $b .N635 2019
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 599.0188 $2 23
090 $a QP364.7 $b .N758 2019
245 0 4 $a The Nociceptin/Orphanin FQ peptide receptor $h [electronic resource] / $c edited by Mei-Chuan Ko, Girolamo Calo.
260 $a Cham : $c 2019. $b Springer International Publishing : $b Imprint: Springer,
300 $a x, 417 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.254
505 0 $a PART I. The N/OFQ-NOP Receptor System -- 1. The History of N/OFQ and the NOP Receptor -- 2. NOP-Targeted Peptide Ligands -- 3. NOP-Targeted Nonpeptide Ligands -- 4. Pharmacological Assays for Investigating the NOP Receptor -- 5. Electrophysiological Actions of N/OFQ -- 6. NOP Receptor Signaling Cascades -- 7.Regulation of the Genes Encoding the ppN/OFQ and NOP Receptor -- PART II. Biological Actions of NOP Ligands -- 8.NOP-Related Mechanisms in Pain and Analgesia -- 9. NOP-Related Mechanisms in Substance Use Disorders -- 10. NOP Receptor Ligands and Parkinson's Disease -- 11. NOP Ligands for the Treatment of Anxiety and Mood Disorders -- 12. The Nociceptin/Orphanin FQ System and the Regulation of Memory -- 13. N/OFQ-NOP System in Food Intake -- 14. N/OFQ-NOP System in Peripheral and Central Immunomodulation -- 15. N/OFQ-NOP System and Airways -- 16. Effects of NOP-Related Ligands in Nonhuman Primates -- PART III. First Clinical Studies with NOP Ligands -- 17. Nociceptin/Orphanin FQ and Urinary Bladder -- 18. Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors -- 19. Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094) -- 20. Correction to: Electrophysiological Actions of N/OFQ.
520 $a The aim of this book is not only to introduce readers with a broad spectrum of biological actions of the NOP receptor, but also to feature a detailed look at the N/OFQ-NOP receptor system, medicinal chemistry, pharmacology, and clinical data of NOP-targeted ligands. This special volume book - for the first time focusing on the NOP receptor - is designed to serve as a useful reference, stimulate more research on the N/OFQ-NOP receptor system, and lead to more development of NOP-related ligands for several therapeutic applications.
650 0 $a Neurotransmitter receptors. $3 581762
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Neurosciences. $3 593561
650 2 4 $a Anesthesiology. $3 645681
650 2 4 $a Pain Medicine. $3 669117
650 2 4 $a Psychopharmacology. $3 644799
700 1 $a Ko, Mei-Chuan. $3 1228967
700 1 $a Calo, Girolamo. $3 1228968
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v v.212. $3 882814
856 4 0 $u https://doi.org/10.1007/978-3-030-20186-9
950 $a Biomedical and Life Sciences (Springer-11642)